Results 161 to 170 of about 19,884 (196)

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies <i>SMARCAL1</i> as a Novel Osteosarcoma Predisposition Gene. [PDF]

J Clin Oncol
Oak N, Chen W, Blake A, Harrison L, O'Brien M, Previti C, Balasubramanian G, Maass K, Hirsch S, Penkert J, Jones BC, Schramm K, Nathrath M, Pajtler KW, Jones DTW, Witt O, Dirksen U, Li J, Sapkota Y, Ness KK, Guenther LM, Pfister SM, Kratz C, Wang Z, Armstrong GT, Hudson MM, Wu G, Autry RJ, Nichols KE, Sharma R.   +29 more
europepmc   +1 more source

Successful Management of Ectopic Adrenocorticotropin-Secreting Thymic Carcinoid With Mitotane: A New Look at an Old Drug. [PDF]

JCEM Case Rep
Zhou X, Xu Y, Peng X, Hu R, Lu L.
europepmc   +1 more source

Establishing a pediatric solid tumor PDX biobank for precision oncology research. [PDF]

Cancer Biol Ther
Akemi Kido L, Rodrigues Marusco M, Aparecida da Silva E, Do Carmo L, Beatriz Teodoro Borges A, Luz Torres Silva F, Silveira Ruas J, Giomo de Lima D, de Abreu Fernandes L, Maia Martin Daiggi C, Aparecida Cardinalli I, Ferreira Euzébio M, Yoshioka Jotta P, Maschietto M, Pini Zenatti P.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis

Journal of Pediatric Urology, 2021
INTRODUCTION Pediatric adrenocortical carcinoma (ACC) is a rare malignancy, encompassing less than 0.2% of all childhood malignancies. Due to the scarcity of this diagnosis, it is often managed according to guidelines established for adults, as there is ...
Jaisa D Evanoff, Sanjay G Patel, Adam J Rensing   +2 more
exaly   +4 more sources

Rare Pediatric Adrenocortical Carcinoma with Oncocytic Change: A Cytologic Dilemma

Endocrine Pathology, 2011
Pediatric adrenocortical carcinoma is extremely rare with a prevalence of 0.3 per million. Adrenocortical neoplasms in children usually present with one of the endocrine abnormalities. Adrenocortical neoplasms cannot be easily diagnosed on cytopathology; hence, the cytomorphological features posing diagnostic dilemmas are discussed in a pediatric ...
Savita Agarwal
exaly   +4 more sources

Predictors of survival in pediatric adrenocortical carcinoma: A Surveillance, Epidemiology, and End Results (SEER) program study

Journal of Pediatric Surgery, 2013
Adrenocortical carcinoma (ACC) is rarely described in children. There is variation in incidence worldwide. This study sought to identify national incidence rates and independent prognostic indicators for children.The SEER database was queried for the years 1973 through 2008 for all patients with ACC less than 20 years of age.
J. Mcateer, Jorge A. Huaco, K. Gow
exaly   +4 more sources

Erythrocytosis as the initial presentation of pediatric adrenocortical carcinoma: A case report and review of the literature

Pediatric blood & cancer, 2023
To the Editor: Erythrocytosis refers to an increase in red blood cells (RBC) in circulation.1 Erythrocytosis caused by functional adrenocortical carcinoma (ACC) with predominant androgen secretion in children is extremely rare in clinical practice.
Yu Lin, Wei Yang, H. Qin, Haiyan Cheng, Shen Yang, Qinghua Ren, Shuangtao Xiao, Lianyuan Yu, Huanmin Wang   +8 more
semanticscholar   +4 more sources

Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma

Cancer Research, 2023
Outcomes for pediatric patients with unresectable, metastatic, or relapsed adrenocortical carcinoma (ACC) are dismal despite aggressive management with multimodality therapies.
Rebecca Epperly, E. Pinto, T. Santiago, H. Sheppard, Michael R. Clay, C. Morton, P. Nguyen, Yinmei Zhou, Mary A. Woolard, Carla O'Reilly, Julie Justice, Walter J Akers, Melissa D. Johnson, Asa Karlstrom, Cheng Cheng, G. Zambetti, A. Davidoff, Raul C. Ribeiro, C. Derenzo   +18 more
semanticscholar   +2 more sources

Surgical Management and Outcomes in Pediatric Adrenocortical Carcinoma: A Pediatric Surgical Oncology Research Collaborative Study

Annals of Surgical Oncology
Pediatric adrenocortical carcinoma (ACC) is a rare and aggressive cancer. The appropriateness of minimally invasive surgery (MIS), role of nodal dissection, and aggressiveness of surgery in patients with metastatic disease remain poorly understood.We performed a retrospective review of patients < 18 years with ACC treated from 2012 to 2022 at 22 ...
Shachi Srivatsa, J. Aldrink, Md Rejuan Haque, Andrew Murphy, Daniel B Gehle, H. Halepota, Erika A. Newman, Keyonna M Williams, P. Mattei, William R. Johnston, Rosa Hwang, Timothy B. Lautz, Samantha A Ayala, N. Piché, Caroline P. Lemoine, Julia G. Debertin, Stephanie F. Polites, David H. Rothstein, K. Riehle, Nzuekoh N. Nchinda, M. Malek, Hannah N. Rinehardt, C. Gestrich, Shannon L. Castle, Adriana Lopez, M. Mayes, Emily K. Myers, Jonathan P. Roach, Brian T. Craig, Dave R. Lal, Jennifer M. Schuh, B. Cromeens, Sindhu V. Mannava, Mary T. Austin, Lauren K. Mayon, Z. Kastenberg, Marshall Wallace, Abigail Alexander, Michael A. Stellon, Hau D. Le, Devashish Joshi, Charbel Chidiac, Daniel S Rhee, Danielle B. Cameron, Alyssa E. Stetson, Barrie S. Rich, R. Glick, Elizabeth A. Fialkowski, Kathryn L Fowler, Rukaya Fareh, Erin G. Brown, Kathleen Doyle, Paige Abril, Christa N. Grant, Roshni Dasgupta, Chloé Boehmer, Sara A. Mansfield   +56 more
semanticscholar   +3 more sources

Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.

Endocrine-Related Cancer
Adrenocortical carcinoma (ACC) is a malignancy with a poor prognosis and high mortality rate. A high tumor mutational burden (TMB) has been found to be associated with poor prognosis in ACC.
Yihao Chen, Jiahong Chen, Yongcheng Shi, Xiaohui Ling, Shumin Fang, Chuanfan Zhong, Fengping Liu, Weide Zhong, X. Bi, Zhong Dong, Jianming Lu   +10 more
semanticscholar   +3 more sources